Meso Scale Discovery, Inc. (MSD), headquartered in the United States, is a leading innovator in the life sciences industry, specialising in high-performance immunoassays and biomarker analysis. Founded in 2006, MSD has established itself as a key player in the development of multiplexed assays that enable researchers to gain deeper insights into complex biological systems. With a strong focus on providing unique, sensitive, and reproducible solutions, Meso Scale Discovery offers a range of core products, including the MSD Discovery platform and custom assay development services. These offerings are distinguished by their ability to deliver high-throughput results with minimal sample volumes, making them invaluable in both clinical and research settings. Recognised for its commitment to advancing scientific discovery, MSD continues to enhance its market position through strategic partnerships and innovative product development, solidifying its reputation as a trusted resource for researchers worldwide.
How does Meso Scale Discovery, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Meso Scale Discovery, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Meso Scale Discovery, Inc., headquartered in the United States, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. However, the company is committed to climate action through its participation in the Science Based Targets initiative (SBTi). Meso Scale Discovery has made a near-term commitment to set reduction targets, although specific numerical targets have not been disclosed. As a current subsidiary of Meso Scale Diagnostics, LLC, Meso Scale Discovery's climate initiatives may be influenced by the broader corporate strategies of its parent company. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focusing on sustainability and emissions reduction. While no absolute emissions numbers are available, Meso Scale Discovery's commitment to the SBTi reflects a proactive approach to addressing climate change. The company is expected to align its practices with industry standards and contribute to the global effort of reducing greenhouse gas emissions in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Meso Scale Discovery, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.